Rating evidence in treatment guidelines
- 31 July 2013
- journal article
- review article
- Published by Wolters Kluwer Health in AIDS
- Vol. 27 (12) , 1839-1846
Abstract
Guidelines for the initiation of combination antiretroviral therapy (cART) in those living with HIV are provided by several national and international treatment guidelines committees. Following recent changes to some of these guidelines, there is now considerable variation between the guidelines in terms of the recommendations for initiation of cART among asymptomatic individuals with high (> 350 cells/mu l) CD4 cell counts. In this review we compare the schemes used for rating evidence by the various committees and assess the strengths and weaknesses of the available evidence for initiating cART at higher CD4 cell counts. (C) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & WilkinsKeywords
This publication has 29 references indexed in Scilit:
- Antiretroviral Treatment of Adult HIV InfectionJAMA, 2012
- GRADE guidelines: 9. Rating up the quality of evidenceJournal of Clinical Epidemiology, 2011
- Prevention of HIV-1 Infection with Early Antiretroviral TherapyNew England Journal of Medicine, 2011
- Routine Screening for Chronic Human Immunodeficiency Virus Infection: Why Don't the Guidelines Agree?Epidemiologic Reviews, 2011
- GRADE guidelines: 3. Rating the quality of evidenceJournal of Clinical Epidemiology, 2011
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tablesJournal of Clinical Epidemiology, 2011
- Effect of Early versus Deferred Antiretroviral Therapy for HIV on SurvivalNew England Journal of Medicine, 2009
- When should antiretroviral therapy for HIV be started?BMJ, 2007
- The Case for Earlier Treatment of HIV InfectionClinical Infectious Diseases, 2004
- Therapy for Early HIV Infection: How Far Back Should the Pendulum Swing?The Journal of Infectious Diseases, 2004